EyePoint (EYPT) Amortization - Intangibles (2019 - 2022)

EyePoint (EYPT) reported Amortization - Intangibles of $205000.0 for Q4 2022, down 66.67% sequentially from $615000.0 in Q3 2022.

EyePoint (EYPT) Amortization - Intangibles (2019 - 2022) Analysis & Trends

EyePoint (EYPT) has 2 years of Amortization - Intangibles data on file, last reported at $205000.0 in Q4 2022.

For the quarter ending Q4 2022, Amortization - Intangibles changed N/A year-over-year to $205000.0; the trailing twelve-month figure through Dec 2023 stood at $820000.0 (down 42.86% YoY), and the FY2022 full-year result was $2.0 million, changed N/A from the prior year.
Amortization - Intangibles retreated to $205000.0 in Q4 2022, from $615000.0 in the prior quarter.
In the past five years, Amortization - Intangibles ranged from a high of $615000.0 in Q1 2019 to a low of $205000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	EyePoint	358.61 Mn	136.07 Mn	168,000.00

Download Data